Patrick is an associate in the Firm's Mergers & Acquisitions practice, and is resident in our New York office. His practice focuses on mergers and acquisitions, private equity and general corporate matters.
Recent matters include the representation of:
Macquarie Infrastructure Corp. (NYSE: MIC) and its related entities in the US$4.475 billion sale of its Atlantic Aviation business to a special purpose entity of Kohlberg Kravis Roberts & Co. L.P.
CM Life Sciences (NASDAQ: CMLF), a SPAC sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, in its US$2 billion business combination with Mount Sinai Genomics, Inc. d/b/a Sema4.
CM Life Sciences II (NASDAQ: CMII), a SPAC sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, in its US$1.23 billion business combination with SomaLogic, Inc., a protein biomarker discovery and clinical diagnostics company.
FG New America Acquisition Corp. (NYSE: FGNA), a SPAC, in its US$800 million business combination with Opportunity Financial, LLC, a leading financial technology platform that focuses on helping middle income, credit-challenged consumers build a better financial path through affordable personal loans.
GenOn in a $620 million restructuring and Term Loan B refinancing of sixteen peaker merchant power plants in NJ, OH and PA.
Avon Rubber p.l.c. (LSE: AVON), a leading provider of life critical personal protection systems to military and first responder markets, in its US$130 million acquisition of Team Wendy, LLC, a leading supplier of critical protective systems including helmets and helmet liner and retention systems for military and first responders.